Literature DB >> 27732787

Nonalcoholic Steatohepatitis.

Ayako Suzuki1, Anna Mae Diehl2.   

Abstract

Nonalcoholic steatohepatitis (NASH) has become a major cause of cirrhosis and liver-related deaths worldwide. NASH is strongly associated with obesity and the metabolic syndrome, conditions that cause lipid accumulation in hepatocytes (hepatic steatosis). It is not well understood why some, but not other, individuals with hepatic steatosis develop NASH. The factors that determine whether or not NASH progresses to cirrhosis are also unclear. This review summarizes key components of NASH pathogenesis and discusses how inherent and acquired variations in regulation of these processes impact the risk for NASH and NASH cirrhosis.

Entities:  

Keywords:  adaptive mechanisms; hepatic fibrosis; hepatocyte damage; lipotoxicity; nonalcoholic fatty liver disease

Mesh:

Year:  2016        PMID: 27732787     DOI: 10.1146/annurev-med-051215-031109

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  46 in total

1.  Pediatric Fatty Liver Disease.

Authors:  Ajay Jain
Journal:  Mo Med       Date:  2019 Mar-Apr

2.  The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.

Authors:  Zhongcao Wei; Na Liu; Xinxing Tantai; Xin Xing; Cailan Xiao; Lirong Chen; Jinhai Wang
Journal:  Hepatol Int       Date:  2018-11-16       Impact factor: 6.047

3.  The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.

Authors:  Yan-Xiao Ji; Zan Huang; Xia Yang; Xiaozhan Wang; Ling-Ping Zhao; Pi-Xiao Wang; Xiao-Jing Zhang; Michele Alves-Bezerra; Lin Cai; Peng Zhang; Yue-Xin Lu; Lan Bai; Mao-Mao Gao; Huan Zhao; Song Tian; Yong Wang; Zhi-Xiang Huang; Xue-Yong Zhu; Yan Zhang; Jun Gong; Zhi-Gang She; Feng Li; David E Cohen; Hongliang Li
Journal:  Nat Med       Date:  2018-01-01       Impact factor: 53.440

4.  Screening of non-alcoholic steatohepatitis (NASH)-related datasets and identification of NASH-related genes.

Authors:  Ming-Jiang Liu; Hu Jin; Yu-Bing Chen; Jing-Jing Yu; Zhen-Ya Guo; Song-Qing He; Yong-Lian Zeng
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

5.  A MicroRNA Linking Human Positive Selection and Metabolic Disorders.

Authors:  Lifeng Wang; Nasa Sinnott-Armstrong; Alexandre Wagschal; Abigail R Wark; Joao-Paulo Camporez; Rachel J Perry; Fei Ji; Yoojin Sohn; Justin Oh; Su Wu; Jessica Chery; Bahareh Nemati Moud; Alham Saadat; Simon N Dankel; Gunnar Mellgren; Divya Sri Priyanka Tallapragada; Sophie Madlen Strobel; Mi-Jeong Lee; Ryan Tewhey; Pardis C Sabeti; Anne Schaefer; Andreas Petri; Sakari Kauppinen; Raymond T Chung; Alexander Soukas; Joseph Avruch; Susan K Fried; Hans Hauner; Ruslan I Sadreyev; Gerald I Shulman; Melina Claussnitzer; Anders M Näär
Journal:  Cell       Date:  2020-10-14       Impact factor: 41.582

6.  Vitamin E sequestration by liver fat in humans.

Authors:  Pierre-Christian Violet; Ifechukwude C Ebenuwa; Yu Wang; Mahtab Niyyati; Sebastian J Padayatty; Brian Head; Kenneth Wilkins; Stacey Chung; Varsha Thakur; Lynn Ulatowski; Jeffrey Atkinson; Mikel Ghelfi; Sheila Smith; Hongbin Tu; Gerd Bobe; Chia-Ying Liu; David W Herion; Robert D Shamburek; Danny Manor; Maret G Traber; Mark Levine
Journal:  JCI Insight       Date:  2020-01-16

7.  hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis.

Authors:  Jing Xiong; Tongyu Liu; Lin Mi; Henry Kuang; Xuelian Xiong; Zhimin Chen; Siming Li; Jiandie D Lin
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

Review 8.  Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease.

Authors:  Ya-Lin Wang; Xiu Zhou; Dong-Li Li; Ji-Ming Ye
Journal:  Acta Pharmacol Sin       Date:  2021-03-17       Impact factor: 6.150

9.  The kinase PKD3 provides negative feedback on cholesterol and triglyceride synthesis by suppressing insulin signaling.

Authors:  Alexander E Mayer; Mona C Löffler; Angel E Loza Valdés; Werner Schmitz; Rabih El-Merahbi; Jonathan Trujillo Viera; Manuela Erk; Thianzhou Zhang; Ursula Braun; Mathias Heikenwalder; Michael Leitges; Almut Schulze; Grzegorz Sumara
Journal:  Sci Signal       Date:  2019-08-06       Impact factor: 8.192

10.  Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet.

Authors:  Daixi Jiang; Jianbin Zhang; Shuangzhe Lin; Yuqin Wang; Yuanwen Chen; Jiangao Fan
Journal:  Front Cell Dev Biol       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.